Commentary on 'Alpha calculus in clinical trials: considerations and commentary for the new millennium'

Stat Med. 2000 Mar 30;19(6):785-99. doi: 10.1002/(sici)1097-0258(20000330)19:6<785::aid-sim520>3.0.co;2-k.

Author

Affiliation

¹ Food and Drug Administration, Center for Drug Evaluation and Review, Office of Biostatistics, 5600 Fishers Lane, Parklawn Building, Room 15B-45, Rockville, MD 20857, USA.

PMID: 10734282
DOI: 10.1002/(sici)1097-0258(20000330)19:6<785::aid-sim520>3.0.co;2-k

No abstract available

MeSH terms

Clinical Trials as Topic*
Data Interpretation, Statistical*
Humans
Probability
Research Design